ASP Isotopes (NASDAQ:ASPI – Get Free Report) and GlyEco (OTCMKTS:GLYE – Get Free Report) are both basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, profitability, risk, institutional ownership and analyst recommendations.
Earnings & Valuation
This table compares ASP Isotopes and GlyEco”s revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
ASP Isotopes | $430,000.00 | 1,307.36 | -$16.29 million | ($0.63) | -12.54 |
GlyEco | N/A | N/A | N/A | N/A | N/A |
GlyEco has lower revenue, but higher earnings than ASP Isotopes.
Analyst Ratings
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
ASP Isotopes | 0 | 0 | 3 | 0 | 3.00 |
GlyEco | 0 | 0 | 0 | 0 | 0.00 |
ASP Isotopes presently has a consensus target price of $4.50, indicating a potential downside of 43.04%. Given ASP Isotopes’ stronger consensus rating and higher probable upside, analysts clearly believe ASP Isotopes is more favorable than GlyEco.
Profitability
This table compares ASP Isotopes and GlyEco’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
ASP Isotopes | N/A | -174.89% | -68.75% |
GlyEco | N/A | N/A | N/A |
Institutional and Insider Ownership
16.8% of ASP Isotopes shares are owned by institutional investors. 21.4% of ASP Isotopes shares are owned by insiders. Comparatively, 22.1% of GlyEco shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
ASP Isotopes beats GlyEco on 5 of the 8 factors compared between the two stocks.
About ASP Isotopes
ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
About GlyEco
GlyEco, Inc. engages in the development and manufacture of coolants, additives and related performance fluids. Its products and services include additives, ethylene glycol and antifreeze. The company was founded by Janet Carnell Lorenz, John Darc Lorenz, II and Todd L. Smith on April 21, 1997 and is headquartered in Rock Hill, SC.
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.